Eckert & Ziegler Strahlen- Und Medizintechnik AG (EUZ) | Finanzwire

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

BRIEF

published on 06/26/2024 at 16:32, 4 months 25 days ago

Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG

Annual General Meeting Dividend Eckert & Ziegler Pentixapharm AG Corporate Split-Off
PRESS RELEASE

published on 06/26/2024 at 16:27, 4 months 25 days ago

Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG
The Annual General Meeting of Eckert & Ziegler SE has approved the split-off of Pentixapharm AG and declared a dividend of EUR 0.05 per share for 2023

Annual General Meeting Dividend Eckert & Ziegler SE Pentixapharm AG Split-off
BRIEF

published on 06/25/2024 at 12:05, 4 months 26 days ago

Eckert & Ziegler Subsidiary Pentixapharm Receives FDA Feedback to Initiate Phase III Trial with PentixaFor

Pentixapharm FDA Phase III Trial Ga68-PentixaFor Primary Aldosteronism Radiopharmaceutical Diagnostic
PRESS RELEASE

published on 06/25/2024 at 12:00, 4 months 26 days ago

Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism
Pentixapharm, a subsidiary of Eckert & Ziegler SE, receives FDA feedback to start Phase III trial with radiopharmaceutical diagnostic Ga68-PentixaFor for Primary Aldosteronism

Eckert & Ziegler FDA Feedback Phase III Trial Pentixapharm Primary Aldosteronism
BRIEF

published on 06/19/2024 at 09:05, 5 months 2 days ago

Eckert & Ziegler and UJF Open State-of-the-Art Actinium-225 Production Facility

Oncology Cancer Therapy Radiopharmaceuticals Isotope Production Actinium-225
PRESS RELEASE

published on 06/19/2024 at 09:00, 5 months 2 days ago

Eckert & Ziegler and UJF Open State-of-the-Art Actinium-225 Production Facility
Eckert & Ziegler and UJF open a state-of-the-art Actinium-225 production facility, aiming to address the increasing demand for Ac-225 in cancer treatments

Eckert & Ziegler Cancer Treatments Production Facility Actinium-225 UJF
BRIEF

published on 05/31/2024 at 09:05, 5 months 21 days ago

Eckert & Ziegler Hosts Second Radionuclide Theranostics Forum in Boston, MA

Radiopharmaceuticals Isotope Production Radiotheranostics Healthcare Innovations
PRESS RELEASE

published on 05/31/2024 at 09:00, 5 months 21 days ago

Eckert & Ziegler Hosts Second Radionuclide Theranostics Forum in Boston, MA
Eckert & Ziegler successfully hosts the 2nd Radionuclide Theranostics Forum in Boston, MA, highlighting advancements in radiopharmaceuticals and fostering industry collaboration

Innovation Eckert & Ziegler Boston Radiopharmaceuticals Radionuclide Theranostics Forum
BRIEF

published on 05/24/2024 at 09:05, 5 months 28 days ago

Eckert & Ziegler Receives "Best Managed Companies Award"

Innovation Eckert & Ziegler Medium-Sized Companies Deloitte Best Managed Companies Award
PRESS RELEASE

published on 05/24/2024 at 09:00, 5 months 28 days ago

Eckert & Ziegler receives “Best Managed Companies Award”
Eckert & Ziegler SE has been awarded the 'Best Managed Companies Award' by Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federation of German Industries for outstanding management in strategy, productivity, innovation, culture, and finance

Corporate Strategy Eckert & Ziegler SE Medium-Sized Companies Best Managed Companies Award Deloitte Private

Accesswire

Published on 11/22/2024 at 00:00, 5 hours 52 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 7 hours 47 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 8 hours 2 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 37 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 9 hours 42 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 10 hours 50 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 15 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 11 hours 53 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 12 hours ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 12 hours ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 22 hours 54 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 10 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 22 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE